Computerized Registry of Cardiovascular Disease Patients
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Ischemic Heart Disease
- Sponsor
- Maccabi Healthcare Services, Israel
- Enrollment
- 110000
- Locations
- 1
- Primary Endpoint
- Number of Patients with Cardiovascular disease
- Status
- Enrolling By Invitation
- Last Updated
- 13 years ago
Overview
Brief Summary
A computerized registry of cardiovascular disease patients in a large health maintenance organization in Israel. The registry is aimed to be used by health professionals to identify cardiovascular disease patients and to follow the courses of their illnesses and risk factors.
Detailed Description
The registry was initiated in 1998 by Maccabi Healthcare services, which is the second largest publicly funded HMO in Israel,serving 24% of the total population with a nationwide distribution. The registry uses advanced information technology that integrates personal computerized community and hospital records, data from laboratory tests, dispensed medications, physiological signals, radiological images, and reports from investigations and procedures.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Clinical Diagnosis of the following:
- •Ischemic Heart Disease,MI,non-MI,congestive heart failure,peripheral vascular disease, cerebrovascular disease CVA,TIA,patients with first AMI diagnosis from community physicians if they were hospitalized for lasting at least 3 days during a 30-day period prior to diagnosis.
- •Patients with prior coronary artery bypass grafting(CABG) or percutaneous coronary intervention (PCI), using relevant Current Procedural Terminology (CPT) codes
Exclusion Criteria
- •patients who were diagnosed as suffering from CHD by primary physician or general hospitals prior to 2000 with no further indication
- •Patients whose primary physician reported that the patient is CHD-free providing adequate medical records
Outcomes
Primary Outcomes
Number of Patients with Cardiovascular disease
Time Frame: Up to 100 years
Secondary Outcomes
- prevalence rates of CVD(up to 100 years)
- Major Adverse Cardiac Events(up to 100 years)
- Number of LDL Tests performed reaching target LDL(up to 100 years)
- Proportion of dyslipidemia patients treated with Statins(up to 100 years)